These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 31490264)
1. Identification of microRNAs as novel biomarkers for esophageal squamous cell carcinoma: a study based on The Cancer Genome Atlas (TCGA) and bioinformatics. Li CY; Zhang WW; Xiang JL; Wang XH; Li J; Wang JL Chin Med J (Engl); 2019 Sep; 132(18):2213-2222. PubMed ID: 31490264 [TBL] [Abstract][Full Text] [Related]
2. Identification and functional characterization of microRNAs reveal a potential role in gastric cancer progression. Li CY; Liang GY; Yao WZ; Sui J; Shen X; Zhang YQ; Peng H; Hong WW; Ye YC; Zhang ZY; Zhang WH; Yin LH; Pu YP Clin Transl Oncol; 2017 Feb; 19(2):162-172. PubMed ID: 27173517 [TBL] [Abstract][Full Text] [Related]
3. Integrated analysis highlights multiple long non‑coding RNAs and their potential roles in the progression of human esophageal squamous cell carcinoma. Li CY; Zhang WW; Xiang JL; Wang XH; Wang JL; Li J Oncol Rep; 2019 Dec; 42(6):2583-2599. PubMed ID: 31638253 [TBL] [Abstract][Full Text] [Related]
4. Identification of prognostic miRNA biomarkers for esophageal cancer based on The Cancer Genome Atlas and Gene Expression Omnibus. Xue J; Jia E; Ren N; Xin H Medicine (Baltimore); 2021 Feb; 100(7):e24832. PubMed ID: 33607850 [TBL] [Abstract][Full Text] [Related]
5. Integrated analysis of genome-wide miRNAs and targeted gene expression in esophageal squamous cell carcinoma (ESCC) and relation to prognosis. Yang H; Su H; Hu N; Wang C; Wang L; Giffen C; Goldstein AM; Lee MP; Taylor PR BMC Cancer; 2020 May; 20(1):388. PubMed ID: 32375686 [TBL] [Abstract][Full Text] [Related]
6. IGF2BP1/UHRF2 Axis Mediated by miR-98-5p to Promote the Proliferation of and Inhibit the Apoptosis of Esophageal Squamous Cell Carcinoma. Fang XY; Sun JJ; Chen SY; Wu KJ; Yu Y; Zhang C; Duan CZ Ann Clin Lab Sci; 2021 May; 51(3):329-338. PubMed ID: 34162562 [TBL] [Abstract][Full Text] [Related]
7. MiR-142-3p as a potential prognostic biomarker for esophageal squamous cell carcinoma. Lin RJ; Xiao DW; Liao LD; Chen T; Xie ZF; Huang WZ; Wang WS; Jiang TF; Wu BL; Li EM; Xu LY J Surg Oncol; 2012 Feb; 105(2):175-82. PubMed ID: 21882196 [TBL] [Abstract][Full Text] [Related]
8. Identification of miR-375 as a potential prognostic biomarker for esophageal squamous cell cancer: A bioinformatics analysis based on TCGA and meta-analysis. Luo HS; Wu DH Pathol Res Pract; 2019 Mar; 215(3):512-518. PubMed ID: 30638952 [TBL] [Abstract][Full Text] [Related]
9. miR-145 expression level in tissue predicts prognosis of patients with esophageal squamous cell carcinoma. Jin W; Luo W; Fang W; Wang Y; Wang L; Shen Q; Liu W; Zhang H Pathol Res Pract; 2019 Jun; 215(6):152401. PubMed ID: 31014553 [TBL] [Abstract][Full Text] [Related]
10. Upregulated miR-483-5p expression as a prognostic biomarker for esophageal squamous cell carcinoma. Xue L; Nan J; Dong L; Zhang C; Li H; Na R; He H; Wang Y Cancer Biomark; 2017; 19(2):193-197. PubMed ID: 28211800 [TBL] [Abstract][Full Text] [Related]
11. Prognostic Value of a Four-miRNA Signature in Patients With Lymph Node Positive Locoregional Esophageal Squamous Cell Carcinoma Undergoing Complete Surgical Resection. Wen J; Wang G; Xie X; Lin G; Yang H; Luo K; Liu Q; Ling Y; Xie X; Lin P; Chen Y; Zhang H; Rong T; Fu J Ann Surg; 2021 Mar; 273(3):523-531. PubMed ID: 31058700 [TBL] [Abstract][Full Text] [Related]
12. Up-regulation of miR-335 predicts a favorable prognosis in esophageal squamous cell carcinoma. Zhang BJ; Gong HY; Zheng F; Liu DJ; Liu HX Int J Clin Exp Pathol; 2014; 7(9):6213-8. PubMed ID: 25337272 [TBL] [Abstract][Full Text] [Related]
13. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer. Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428 [TBL] [Abstract][Full Text] [Related]
14. microRNA-messenger RNA regulatory network of esophageal squamous cell carcinoma and the identification of miR-1 as a biomarker of patient survival. Wei Q; Li X; Yu W; Zhao K; Qin G; Chen H; Gu Y; Ding F; Zhu Z; Fu X; Sun M J Cell Biochem; 2019 Aug; 120(8):12259-12272. PubMed ID: 31017699 [TBL] [Abstract][Full Text] [Related]
15. Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance. Shi KQ; Lin Z; Chen XJ; Song M; Wang YQ; Cai YJ; Yang NB; Zheng MH; Dong JZ; Zhang L; Chen YP Oncotarget; 2015 Sep; 6(28):25093-108. PubMed ID: 26231037 [TBL] [Abstract][Full Text] [Related]
16. Diagnostic and prognostic implications of a serum miRNA panel in oesophageal squamous cell carcinoma. Wu C; Wang C; Guan X; Liu Y; Li D; Zhou X; Zhang Y; Chen X; Wang J; Zen K; Zhang CY; Zhang C PLoS One; 2014; 9(3):e92292. PubMed ID: 24651474 [TBL] [Abstract][Full Text] [Related]
17. MiR-106b-5p regulates esophageal squamous cell carcinoma progression by binding to HPGD. Yang F; Sun Z; Wang D; Du T BMC Cancer; 2022 Mar; 22(1):308. PubMed ID: 35317779 [TBL] [Abstract][Full Text] [Related]
18. Overexpression of UBE2C in esophageal squamous cell carcinoma tissues and molecular analysis. Li R; Pang XF; Huang ZG; Yang LH; Peng ZG; Ma J; He RQ BMC Cancer; 2021 Sep; 21(1):996. PubMed ID: 34488675 [TBL] [Abstract][Full Text] [Related]
19. A novel serum microRNA signature to screen esophageal squamous cell carcinoma. Huang Z; Zhang L; Zhu D; Shan X; Zhou X; Qi LW; Wu L; Zhu J; Cheng W; Zhang H; Chen Y; Zhu W; Wang T; Liu P Cancer Med; 2017 Jan; 6(1):109-119. PubMed ID: 28035762 [TBL] [Abstract][Full Text] [Related]
20. Integrative analysis of negatively regulated miRNA-mRNA axes for esophageal squamous cell carcinoma. Peng S; Zhang S; Fan X; Zhu J; Liu C; Yue Y; Wang T; Zhu W Cancer Biomark; 2023; 37(3):191-203. PubMed ID: 37302024 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]